Katy Tait
About Katy Tait
Katy Tait serves as the Head of Transfer Pricing at Dechra Pharmaceuticals PLC, a position she has held since 2017. With prior experience at EY and Solvay, she has a strong background in corporate tax and transfer pricing.
Work at Dechra Pharmaceuticals
Katy Tait has served as the Head of Transfer Pricing at Dechra Pharmaceuticals PLC since 2017. In this role, she is responsible for managing the company's transfer pricing strategies and ensuring compliance with international tax regulations. Her position is based in Northwich, Cheshire West and Chester, United Kingdom. Under her leadership, the transfer pricing function has been aligned with the company's global operations.
Previous Experience at EY
Before joining Dechra Pharmaceuticals, Katy Tait worked at EY as a Corporate Tax Advisor from 1998 to 2003. During her five-year tenure, she provided tax advisory services to various clients, focusing on corporate tax compliance and planning. This experience laid a strong foundation for her subsequent roles in transfer pricing and international tax.
Experience at Solvay
Katy Tait worked at Solvay as an International Tax Manager specializing in transfer pricing from 2008 to 2017. Over her nine years at the company, she developed and implemented transfer pricing policies that supported the company's international operations. Her role involved ensuring compliance with local and international tax laws while optimizing the company's tax position.
Education and Expertise
Katy Tait studied at the University of Leeds, where she earned a Bachelor of Arts degree from 2003 to 2007. Her academic background has equipped her with a solid understanding of economics and business, which she applies in her professional roles in transfer pricing and corporate tax.